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INTRODUCTION
Activation of signal transduction pathways by growth factors
is frequently used in development as a mechanism to specify
distinct cell fates. In the case of the C. elegans hermaphrodite,
vulval cell fate specification (reviewed by Greenwald, 1997;
Sternberg and Han, 1998) begins at the end of the second larval
stage with the secretion of LIN-3 (Hill and Sternberg, 1992),
an EGF-like growth factor, from the gonadal anchor cell. Six
Pn.p cells, P3.p-P8.p, comprise the vulval precursor cells
(VPCs). These cells express LET-23 (Aroian et al., 1990;
Kaech et al., 1998; Simske et al., 1996), an EGF receptor-like
protein, and are competent to respond to overexpressed LIN-3
by adopting vulval fates (Hill and Sternberg, 1992; Katz et al.,
1995). However, in the presence of physiological levels of LIN-
3, only P6.p adopts a primary vulval fate. This response is
transduced through LET-60 (RAS) (Beitel et al., 1990; Han and
Sternberg, 1990) and SUR-1/MPK-1 (MAP kinase) (Lackner
et al., 1994; Wu and Han, 1994), and is accompanied by the
activation of LIN-12, a NOTCH-like molecule (Yochem et al.,
1988), on adjacent P5.p and P7.p, which causes these cells to
adopt secondary vulval fates (Simske and Kim, 1995). The
remaining VPCs, P3.p, P4.p and P8.p, do not adopt vulval
fates, and fuse with the hypodermal syncytium, hyp7.
Given the likely diffusible nature of LIN-3, mechanisms
must exist to ensure that normally only a subset of the VPCs
responds to the growth factor. A ligand-independent gain-of-
function allele of let-23, sa62, confers ectopic vulval fate
transformations in P3.p and P4.p at high frequency (Katz et al.,
1996), indicating that receptor activation is sufficient to drive
cell differentiation. Under physiological conditions, positional
selectivity for cell fate determination might be achieved by
dependency on a threshold level of LET-23 pathway activation,
which is normally achieved only by the VPC closest to the
anchor cell, the source of LIN-3. Consistent with this model,
P6.p is positioned closest to the anchor cell and invariantly
responds to LIN-3.
Genetic studies of negative regulation of vulval development
indicate that additional mechanisms operate to ensure the
selective response of P6.p to LIN-3. Although ectopically
activated LET-23 induces vulval fate transformations at high
frequency in P3.p and P4.p, the posteriorly expressed mab-5
homeobox gene inhibits this response in the most posterior
Pn.p cell, P8.p (Clandinin et al., 1997). Another mechanism of
restricting the response to LIN-3 involves two classes of genes
that function redundantly to inhibit vulval fates. Animals that
harbor loss-of-function mutations both in a class A and class
B ‘synmuv’ gene display a synthetic multivulva phenotype
because of the adoption of vulval fates by most of the VPCs
(Ferguson and Horvitz, 1989). This vulval induction is
independent of the LIN-3-producing anchor cell, but dependent
on LET-23 and its downstream effectors (Ferguson et al., 1987;
Huang et al., 1994; Lu and Horvitz, 1998), raising the
possibility that this pathway exists to repress low, but
functional, levels of ligand-independent activity by the LET-23
pathway. Molecular identification of some of the synmuv genes
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Negative regulation of receptor tyrosine kinase (RTK)/RAS
signaling pathways is important for normal development
and the prevention of disease in humans. We have used a
genetic screen in C. elegans to identify genes that
antagonize the activity of activated LET-23, a member of
the EGFR family of RTKs. We identified two loss-of-
function mutations in dpy-22, previously cloned as sop-1,
that promote the ability of activated LET-23 to induce
ectopic vulval fates. DPY-22 is a glutamine-rich protein
that is most similar to human TRAP230, a component of a
transcriptional mediator complex. DPY-22 has previously
been shown to regulate WNT responses through inhibition
of the b -catenin-like protein BAR-1. We provide evidence
that DPY-22 also inhibits RAS-dependent vulval fate
specification independently of BAR-1, and probably
regulates the activities of multiple transcription factors
during development. Furthermore, we demonstrate that
although inhibition of BAR-1-dependent gene expression
has been shown to require the C-terminal glutamine-rich
region, this region is dispensable for inhibition of RAS-
dependent cell differentiation. Thus, the glutamine-rich
region contributes to specificity of this class of mediator
protein. 
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and RNA interference experiments suggest that this pathway
comprises components of a histone deacetylase complex,
which represses LET-23-dependent gene expression (Chen and
Han, 2001; Lu and Horvitz, 1998; Solari and Ahringer, 2000).
Several genes have been identified whose properties do not
fully resemble the synmuv genes, but nevertheless, function as
negative regulators of vulval induction. These include unc-
101(AP47 medium chain of trans-Golgi AP-1 complexes) (Lee
et al., 1994), sli-1(c-CBL) (Yoon et al., 1995), gap-1 (Hajnal
et al., 1997), ark-1 (ACK-related tyrosine kinase) (Hopper et
al., 2000) and lip-1 (MAP kinase phosphatase) (Berset et al.,
2001). Mutations in these genes suppress loss-of-function
mutations in the let-23 pathway that cause vulvaless
phenotypes, and in different genetic backgrounds, they
enhance the frequency of multivulva phenotypes, indicating
they affect all six VPCs, similar to the synmuv genes. These
negative regulators may function to raise the requirement for
the amount of LET-23 pathway activity necessary to drive a
functional response.
To address whether these are the only mechanisms and
points of negative regulation of the response to LIN-3, we
performed a genetic screen for mutations that enhance the
frequency of ectopic vulval fate transformations in the presence
of gain-of-function let-23(sa62). We isolated two new alleles
of sop-1 (Zhang and Emmons, 2000), which has recently been
found to be allelic to the older locus, dpy-22 (Meneely and
Wood, 1987) (H. Sawa, personal communication). DPY-22 is
most closely related to human TRAP230 (Ito et al., 1999;
Nagase et al., 1996; Philibert et al., 1998), a component of the
transcriptional mediator complex (Ito et al., 1999), and has
been shown to be an inhibitor of WNT-dependent ray
formation in the C. elegans male tail (Zhang and Emmons,
2000). We describe some of the phenotypes of our new dpy-22
alleles, and present evidence that DPY-22 also is an inhibitor
of RAS-dependent vulval fate specification, independent of its
role in regulating WNT signaling.
MATERIALS AND METHODS
Strains and mutagenesis
C. elegans were cultured at 20°C using standard protocols (Brenner,
1974). Alleles used in this work were: pry-1(mu38) (Maloof et al.,
1999) on LGI; let-23(sy1) (Aroian and Sternberg, 1991), let-
23(sa62gf) (Katz et al., 1996) and unc-4(e120) (White et al., 1992)
on LGII; pha-1(e2123ts) (Granato et al., 1994) on LGIII; let-
60(n1046gf) (Beitel et al., 1990; Ferguson and Horvitz, 1985), unc-
31(e169) (Avery et al., 1993) and dpy-4(e1166) (Cox et al., 1980) on
LGIV; him-5(e1490) (Hodgkin et al., 1979) on LGV; and lon-2(e678)
(Brenner, 1974), bar-1(ga80) (Eisenmann et al., 1998), bar-1(mu63)
(Maloof et al., 1999), dpy-6(e14) (Brenner, 1974), dpy-22(bx93)
(Zhang and Emmons, 2000), egl-15(n484) (Trent et al., 1983) and
unc-9(e101) (Brenner, 1974) on LGX. Genetic balancers used were:
mnC1 [dpy-10(e128) unc-52(e444)] (Herman, 1978; Sigurdson et al.,
1984) on LGII; nT1[let(m435)] on LGIV and LGV (Rogalski and
Riddle, 1988). All let-23(sa62) strains carried the linked mutation
unc-4(e120), and heterozygous let-23(sa62)/+ strains were balanced
with mnC1. let-60(n1046)/+ strains carried the linked marker unc-
31(e169) and were balanced by nT1[let(m435)].
bar-1(mu63) was previously reported to have a mutation causing
a L130F change (Maloof et al., 1999), which we did not detect in the
extant bar-1(mu63) strains. In order to determine the molecular
lesion in bar-1(mu63), we amplified 1 kb regions of bar-1 genomic
DNA from bar-1(mu63) animals by PCR, and directly sequenced the
products. Primer sets used included BAR1-6 5 ¢ -ttc agt tct act tgt cta
ttg gtg tgc-3 ¢ and BAR1-7 5 ¢ -cac atg gta gtc cgc gac ttg tac-3 ¢ ; BAR1-
8 5 ¢ -cga gaa ttg acc agc tcc aga aga g-3¢ and BAR1-9 5 ¢ -gc tgc tta
ctg atg aag ccg gtg-3 ¢ ; and BAR1-10 5 ¢ -gc ttt gtg cac aac ctc ctg taa
g-3 ¢ and BAR1-11 5 ¢ -ct ctt cat ccg gca gac aaa tcg-3. After
sequencing 36% of the bar-1 genomic locus, we identified a C to T
mutation at position 39108 of C54D1 in bar-1(mu63) animals. This
change was detected on both strands, and not in N2 animals. This
mis-sense mutation is predicted to cause a G524D change in the
BAR-1 protein. Linkage of bar-1(mu63) to dpy-22(sy622) was
confirmed by DNA sequencing. Linkage of bar-1(ga80) to dpy-
22(sy622) was confirmed by PCR and digestion with MseI, which
detects the MseI restriction site created by the ga80 C to T point
mutation. 
let-23(sa62); him-5(e1490) animals were subjected to standard
mutagenesis with ethylmethanesulfonate (Brenner, 1974). One
thousand F1 offspring were picked to individual plates, and those
segregating adult males with ventral protrusions were saved.
Molecular biology
Full-length dpy-22 used for PCR-based rescue was amplified by PCR
(Expand Long, Roche) from positions 21115 to 6068 of cosmid
F47A4 with the primers 5 ¢ -gtc ccg tta tga taa cgt atc tcc aag-3¢ and
5¢ -caa gcg tta tct tga tga cgc ggt c-3¢ . The PCR fragment was injected
at 10 ng/m l with pPD118.33 (myo-2::gfp) (10 ng/ m l) and pBSSK
(Stratagene) (160 ng/m l) into dpy-6(e14) dpy-22(sy622); stDp2
animals. Rescuing arrays were subsequently crossed into dpy-
22(sy622) single mutants.
A full-length dpy-22 gene spanning 20759 to 6464 of cosmid
F47A4 was reconstructed in pBR322 as follows. First, an XhoI
fragment from F47A4 (20759-10290) was cloned into the SalI site of
pBR322 to yield pBRF47A4Xh. This plasmid was digested with AgeI,
and an AgeI fragment from F47A4 (10406-6464) was introduced into
this vector, to generate pBRsop1FL, which harbors a full-length dpy-
22 gene. dpy-22::gfp, dpy-22 2548::gfp and dpy-22 2141::gfp
transgenes were constructed using overlap extension PCR (High
Fidelity, Roche) to make C-terminal in-frame translational fusions
between appropriately truncated dpy-22 fragments and gfp. In all
cases, codons encoding two glycine residues were placed between the
two genes, and the fusions were made to the codon encoding the first
Ser residue of GFP. dpy-22 fragments were amplified by PCR from
F47A4 using the 5¢ primer sop1-17 5 ¢ -ct tat gtt cca cgg tat cat caa tcc-
3¢ and the 3 ¢ primer sop1-28 5 ¢ -c ttc tcc ttt act tcc tcc gta ctg att tgg
tgg ttg ttg gtt g-3 ¢ ; sop1-26 5¢ -c ttc tcc ttt act tcc tcc ttt ctg ctg ctc cac
aag ttg ttg atg g-3 ¢ ; or sop1-35 5 ¢ - c ttc tcc ttt act tcc tcc gaa cat tct
gaa ctt cca tcc gcc-3¢ , for dpy-22::gfp, dpy-22 2548::gfp and dpy-22
2141::gfp, respectively. gfp fragments included the unc-54 3¢
untranslated region, and were amplified by PCR from pPD95.79 with
the 5 ¢ primers sop1-34 5¢ -aat cag tac gga gga agt aaa gga gaa gaa ctt
ttc act gg-3¢ , sop1-33 5¢ -cag cag aaa gga gga agt aaa gga gaa gaa ctt
ttc act gg-3¢ or sop1-32 5¢ -aga atg ttc gga gga agt aaa gga gaa gaa ctt
ttc act gg-3 ¢ , for dpy-22::gfp, dpy-22 2548::gfp, and dpy-22 2141::gfp,
respectively, and the 3 ¢ primer unc54-5 5¢ -a taa gaa tgc ggc cgc aaa
cag tta tgt ttg gta tat tgg gaa tg-3¢ . The individual fragments were
purified by agarose gel electrophoresis, mixed in the appropriate
combinations, and then subjected to PCR in the presence of the 5 ¢
primer sop1-17, and the 3 ¢ primer unc54-5. The dpy-22::gfp fusion
was digested with NotI and cloned into NotI-digested pBRsop1FL.
dpy-22 2548::gfp and dpy-22 2141::gfp truncations were digested
with BstEII and NotI, and cloned into BstEII/NotI-digested
pBRsop1FL. dpy-22::gfp and dpy-22 2548::gfp transgenes were
injected at 10 ng/ m l with pPD118.33 (myo-2::gfp) (10 ng/ m l) and 160
ng/m l of pBSSK into dpy-6(e14) dpy-22(bx93)/dpy-22(sy622)
animals. dpy-22 2141::GFP was injected at 12.5 ng/ m l with pBX-1
(Granato et al., 1994) (100 ng/ m l) and pBSSK (37.5 ng/ m l) into pha-
1(e2123ts) animals.
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Identification of sy622 and sy665 as alleles of dpy-22/sop-1
sy622 and sy665 were placed on LGX by crossing N2 males into
mutant hermaphrodites and observing that 100% of F1 males were
small/dumpy (Dpy) and had abnormal tails (Mab). Three-factor
mapping was carried out following the small/Dpy and egg-laying-
defective (Egl) phenotypes of sy622. sy622 was placed between
lon-2 and unc-9 as 6/11 Lon non-Unc and 4/11 Unc non-Lon
recombinants picked up the mutation. sy622 was placed between dpy-
6 and unc-9 as 6/13 Dpy non-Unc and 8/10 Unc non-Dpy
recombinants picked up sy622. sy622 was placed between lon-2 and
egl-15 as 23/26 Lon-non-Egl and 4/33 Egl non-Lon recombinants
picked up sy622. Using sy622 egl-15 double mutants and CB4856, a
Hawaiian isolate of C. elegans, Egl-non sy622 recombinants were
generated that allowed us to analyze the positions of crossovers by
the absence or presence of single nucleotide polymorphisms (SNPs)
from CB4856 (Wicks et al., 2001). sy622 was mapped to the left of
the SNP at 36555 in F47A4. Using dpy-6 sy622 double mutants and
CB4856, and picking Dpy non-sy622 and sy622 non-Dpy
recombinants, sy622 was mapped to the right of the SNP at 19169 of
F15G9. Owing to the unhealthiness of sy622 animals, cosmids from
this region initially were coinjected with pPD118.33 (myo-2::gfp) and
pBX-1 into pha-1(e2123ts) animals, and stable extrachromosomal
arrays were crossed into sy622 animals to test for rescue. Initial
attempts at rescue failed using this strategy. Later, cosmid F47A4 (30
ng/m l) was co-injected with pPD118.33 (myo-2::gfp)(10 ng/ m l) and
pBSSK (140 ng/ m l) into pal-1(e2091); him-5(e1490); dpy-22(bx93)
animals. Arrays conferring functional rescue in this background were
crossed into sy622 animals and found to rescue all of the sy622
phenotypes. dpy-22 genomic DNA was amplified in 1 kb pieces from
sy622 and sy665 worms, and the products directly sequenced.
Mutations were confirmed by sequencing both strands, and comparing
the sequencing data from N2, sy622 and sy665 animals in the
appropriate regions. 
RNAi
Exon 17 from dpy-22 was amplified by PCR from the cosmid F47A4
with the primers 5¢ -tta ata cga ctc act ata ggg aga cat tcg aac tag ctc
cag aga aac-3¢ and 5¢ -tta ata cga ctc act ata ggg aga atc aaa tgg gta ctt
ccc agc ttc-3¢ , which introduce a T7 bacteriophage promoter at both
ends of the fragment. An intronless GFP gene was amplified from the
plasmid pPD79.44, with the primers 5 ¢ -tta ata cga ctc act ata ggg aga
tga gta aag gag aag aac ttt tca c-3¢ and 5¢ -tta ata cga ctc act ata ggg
aga cta ttt gta tag ttc atc cat gcc atg-3¢ , which also add a T7 promoter
to both ends of the PCR product. dsRNA was synthesized in vitro
using the MEGAscript T7 kit (Ambion). The presence of dsRNA was
confirmed by agarose gel electrophoresis, and quantified by
spectrophotometry. L1 stage hermaphrodites were incubated in 12 m l
M9 buffer containing 1.5 mg/ml total RNA and OP50 (A600 nm=1.0)
for 24 hours at 20°C. After incubation, worms were recovered and
placed on standard NG plates with OP50, and allowed to develop to
the mid-L4 stage, at which time they were examined by Nomarski.
Vulval induction assay and gonad ablations
Vulval development was scored during the L4 stage under Nomarski
optics (Sternberg and Horvitz, 1986). Nuclei in the ventral region of
the worm that were not of hypodermal, neuronal or muscle descent
were counted. In wild-type animals, 22 nuclei arise from vulval fates.
The number of vulval nuclei is used to extrapolate how many of the
Pn.p cells were induced to adopt vulval fates. A vulval precursor cell
(VPC) in which both daughter cells divide one more time, and both
granddaughters divide to generate seven or eight great granddaughters
and no hypodermal tissue, is scored as 1.0 cell induction. A VPC in
which one daughter fuses with the hypodermis, and one daughter
continues to divide over the next two generations, resulting in four
great granddaughter cells is scored as 0.5 cell induction. In wild-type
animals, P5.p, P6.p and P7.p each undergo the equivalent of 1.0 cell
induction, whereas the other Pn.p cells do not adopt vulval fates,
resulting in an overall cell induction of 3.0. Animals displaying a cell
induction of more than 3.0 are multivulva, and animals with a cell
induction less than 3.0 are vulvaless. Laser ablations were conducted
using a standard protocol (Bargmann and Avery, 1995). Gonadal cells
(Z1, Z2, Z3 and Z4) were ablated during the L1 stage.
RESULTS
sy622 and sy665 promote vulval fate specification
To identify new negative regulators of LET-23-dependent
vulval fate specification, we employed a screen using a gain-
of-function allele of let-23, sa62. let-23(sa62) encodes a
receptor with a mis-sense mutation changing C359Y in the
extracellular domain (Katz et al., 1996). In wild-type
hermaphrodites, only three VPCs, P5.p-P7.p, adopt vulval
fates, whereas in 98% of hermaphrodites homozygous for let-
23(sa62), one additional Pn.p, usually P3.p and/or P4.p,
adopts a vulval fate (Table 1; see Table 4) (Katz et al., 1996).
This ectopic induction, as well as the normal induction
displayed by P5.p-P7.p is independent of the LIN-3-producing
anchor cell in the gonad, suggesting that when expressed at
these levels, the receptor is ligand independent (see Table 4)
(Katz et al., 1996). Male gonads do not give rise to an anchor
cell, and their Pn.p cells do not normally adopt vulval fates.
However, despite the ligand-independence of LET-
23(C359Y), this activated receptor is unable to cause male
Pn.p cells to adopt vulval fates at high frequency (data not
shown). We hypothesized that vulval tissue formation in
homozygous let-23(sa62) males could be used as a sensitized
assay to identify inhibitors of vulval fate specification. We
mutagenized let-23(sa62); him-5(e1490) hermaphrodites with
EMS, and looked for F1 animals that segregated a high
percentage of progeny males exhibiting vulval tissue. From a
pilot screen of 1000 haploid genomes, three mutations were
isolated. Two alleles, sy622 and sy665, resembled each other
in that mutant worms shared additional phenotypes (see
below), whereas the third mutation seemed to affect only Pn.p
fates.
To determine whether sy622 and sy665 affected vulval fate
specification only in male Pn.p cells, we introduced these
mutations into a sensitized hermaphrodite background.
Hermaphrodites heterozygous for let-23(sa62) have mostly
wild-type vulvae, but occasionally some animals display
ectopic vulval tissue (Table 1). sy622 and sy665 enhance the
frequency of ectopic vulval fate specification in let-23(sa62)/+
animals (Table 1), indicating that the mutations also affect the
response of hermaphrodite Pn.p cells to activated LET-23, and
that some regulators of LET-23 signaling are shared between
male and hermaphrodite Pn.p cells. 
We tested whether the multivulva-enhancing effect of sy622
was unique to let-23(sa62), or reflected an interaction with
activated RAS. let-60(n1046) is a gain-of-function let-60 allele
that encodes a RAS protein with a G13E change (Beitel et al.,
1990). Seventy-three percent of let-60(n1046) homozygotes
display ectopic vulval cell fate differentiation (Table 1).
However, similar to let-23(sa62)/+ animals, let-60(n1046)/+
heterozygotes have mostly wild-type vulvae (Table 1). We
therefore used let-60(n1046)/+ as a sensitized background to
examine specifically the interaction of sy622 with activated
RAS. sy622 enhanced ectopic vulval fate specification in a let-
60
60(n1046)/+ background (Table 1), consistent with the sy622
mutation increasing the response to RAS activation.
We also tested if sy622 and sy665 could affect vulval fate
specification in the central VPCs, P5.p-P7.p, which are
normally specified to form vulval tissue. We found that both
sy622 and sy665 could restore the ability of P6.p to adopt a
vulval fate in the presence of the lin-3(n378) or let-23(sy1)
reduction-of-function mutations, which reduce RAS
signaling (Table 1). However, many of these double mutants
still do not display wild-type vulval induction, indicating
sy622 and sy665 do not bypass the requirements for RAS
signaling.
sy622 and sy665 have additional phenotypes
In addition to enhancing vulval fate specification in the
presence of activated LET-23, the sy622 and sy665 mutations
cause other phenotypes. sy622 and sy665 hermaphrodites have
a 90% penetrant egg-laying defect (Table 2), and, as young
adults, are dumpyish and only about 70% of the size of wild-
type animals (Fig. 1A-C; Table 2). In addition, 95% of sy622
and sy665 adult males have abnormal ray development in the
tail (Fig. 1D-F; Table 2). Given the shortened body length of
sy622 and sy665 animals, we asked whether the effect on
ectopic vulval fate specification might indirectly result from a
reduced distance between the anchor cell and P3.p, P4.p and
P8.p. We, therefore, introduced the dpy-4(e1166) mutation,
which comparably reduces body length (Table 2), into let-
23(sa62)/+ animals. Unlike sy622 and sy665, dpy-4(e1166) did
not significantly enhance ectopic vulval fate specification in
this background, indicating that the effect of sy622 and sy665
on vulval induction is not due to a general reduction in body
size (Table 1). 
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Table 1. sy622 and sy665 promote vulval development
% P6.p
Relevant genotype % Vul* induction† % Muv‡ VPC induction§ n¶ P value**
N2 0 100 0 3.0±0.0 31
let-23(sa62) 0 100 98 4.3±0.6 42
let-23(sa62)/+ 0 100 4 3.1±0.3 26
sy622 0 100 3 3.0±0.2 35
sy665 0 100 2 3.0±0.0 50
let-23(sa62)/+; sy622 0 100 96 4.9±0.8 23 <0.000001 versus let-23(sa62)/+
let-23(sa62)/+; sy665 0 100 95 4.1±0.7 20 0.000001 versus let-23(sa62)/+
let-23(sa62)/+; dpy-4(e1166) 0 100 15 3.1±0.2 26 0.61 versus let-23(sa62)/+
let-60(n1046) 0 100 73 4.0±0.8 22
let-60(n1046)/+ 0 100 4 3.1±0.4 24
let-60(n1046)/+; sy622 0 100 91 4.2±0.8 23 <0.000001 versus let-60(n1046)/+
lin-3(n378) 96 35 0 0.7±1.0 51
lin-3(n378); sy622 84 86 0 1.6±0.9 37 0.00002 versus lin-3(n378)
lin-3(n378); sy665 78 76 0 1.6±1.0 45 0.00005 versus lin-3(n378)
let-23(sy1) 100 29 0 0.5±0.9 24
let-23(sy1); sy622 75 90 0 2.1±0.9 20 <0.000001 versus let-23(sy1)
let-23(sy1); sy665 62 90 5 2.3±0.8 21 <0.000001 versus let-23(sy1)
*Vulvaless. Percentage of animals that have less than three VPCs adopting vulval fates.
†Percentage of animals with P6.p adopting a vulval fate.
‡Multivulva. Percentage of animals that have more than three VPCs adopting vulval fates.
§Average number of VPCs that adopt vulval fates.
¶Number of animals assayed.
**P values were calculated for VPC induction using Student’s t-test.
Table 2. sy622 and sy665 animals have multiple phenotypes
Relevant genotype Body length* % Egl† % Mab‡ P value§
N2 87±5 (n=23) 0 (n=30) 3 (n=34)
sy622 61±6 (n=23) 92 (n=61) 95 (n=39) <0.00001
sy665 64±4 (n=22) 100 (n=36) 100 (n=35) <0.00001
let-23(sa62)/+; dpy-4(e1166) 58±3 (n=20) nd nd <0.00001
sy622; syEx538 [F47A4] 88±5 (n=20) 8 (n=24) 0 (n=25) 0.47
sy622; syEx539 [dpy-22 PCR] 84±5 (n=20) 11 (n=28) 9 (n=23) 0.09
dpy-22(bx93) 83+4 (n=20) 0 (n=30) 3 (n=33) 0.002
dpy-22(sy622)/dpy-22(bx93) 81±5 (n=18) 13 (n=23) NA 0.0007
bar-1(mu63) dpy-22(sy622) 65±5 (n=20) 93 (n=30) 100 (n=25) 0.018
dpy-22(sy622); syEx554 [dpy-22:: gfp] 93±4 (n=23) 0 (n=39) 4 (n=27) 0.00005
dpy-22(sy622); syEx558 [dpy-22 2548:: gfp] 90±5 (n=26) 0 (n=33) 4 (n=25) 0.07
*Body length of young adults ( · 0.01 mm).
†Percentage of animals that are egg-laying defective.
‡Percentage of males that have abnormal ray development.
§P values were calculated for body length compared with N2 using Student’s t-test.
n, number of animals assayed; NA, not applicable; nd, not determined.
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sy622 and sy665 are strong loss-of-function alleles
of dpy-22/sop-1
Based on the similarity in phenotypes between sy622 and
sy665, and their common linkage to the X chromosome, we
tested whether they were allelic. These recessive alleles failed
to complement each other for egg-laying and body size defects,
suggesting that they define a single locus (data not shown). We
three-factor mapped sy622 between dpy-6 and egl-15 on the
genetic map, and using single nucleotide polymorphisms in
CB4856, a Hawaiian isolate of C. elegans, we placed sy622
between the cosmids F15G9 and F47A4 on the physical map.
Cosmid F47A4 rescued the egg-laying, body size and male tail
defects (Table 2). A PCR fragment encompassing the complete
predicted coding region of only F47A4.2, sop-1 (Zhang and
Emmons, 2000) (Fig. 2A), also rescued the egg-laying, body
size and male tail defects (Table 2).
F47A4.2/sop-1 has recently been found to be
allelic to an older genetic locus, dpy-22
(Meneely and Wood, 1987) (H. Sawa, personal
communication). When crossed into a let-
23(sa62)/+; sy622 background, extra-
chromosomal arrays containing either F47A4
or the dpy-22 PCR product suppressed the
ectopic vulval fate specification observed in
these animals (Table 3). These results suggest
that all of the sy622 phenotypes result from
mutation of a single gene, dpy-22. We then
sequenced dpy-22 genomic DNA from sy622
and sy665 animals. We found that relative to
wild-type animals, sy622 animals harbored a C
to T mutation at position 13,100 of F47A4,
which changes a CAG glutamine codon in exon
12 to an Amber STOP codon. sy665 animals
harbored a C to T mutation at position 11,718
of F47A4, which changes a CAA glutamine
codon in exon 13 to a TAA Ochre STOP codon.
The mutant DNA in sy622 and sy665 animals
is predicted to truncate the DPY-22 protein
after amino acids 1697 and 2141, respectively
(Fig. 2B). 
dpy-22 was cloned as sop-1, by virtue of the
isolation of non-Dpy alleles that suppress the
ray loss phenotype conferred by a regulatory
region mutation in the homeobox gene pal-1
(Zhang and Emmons, 2000). The dpy-22
alleles that suppress pal-1(e2091) consist of
one splicing mutation and three nonsense
mutations, with the strength of the allele
correlated with the extent of the predicted C-
terminal truncation. dpy-22(bx93) and dpy-
22(bx92) are the strongest alleles, and they are
expected to make proteins that are truncated
after amino acids 2548 and 3165, respectively.
RNAi experiments indicate that all of these
dpy-22 alleles are reduction-of-function
mutations, raising the possibility that dpy-
22(sy622) and dpy-22(sy665) are more severe
loss-of-function alleles, because they would
cause even earlier truncations than would dpy-
22(bx93). Consistent with this notion, recent
RNAi experiments against dpy-22, and double
mutant analyses using the dpy-22 alleles that suppress pal-
1(e2091) and either unc-37 or sur-2 also have revealed a ray
loss phenotype (Zhang and Emmons, 2002), similar to that
observed in dpy-22(sy622) and dpy-22(sy665) single mutants
(Fig. 1). This observation suggests that ray development is
ultimately compromised when DPY-22 pathway activity is
reduced below a certain threshold. In addition, we find that the
loss-of-function allele dpy-22(bx93) weakly promotes ectopic
vulval fate transformations in a let-23(sa62)/+ background
(Table 3). Moreover, dpy-22(bx93) fails to complement dpy-
22(sy622) for enhancing ectopic vulval fate specification in the
presence of let-23(sa62)/+ (Table 3), providing further
evidence that DPY-22 negatively regulates vulval development.
To examine directly the effects of reducing DPY-22 levels on
vulval development, we used RNAi against dpy-22. In an
Fig. 1. sy622 and sy665 animals have multiple phenotypes. Scale bars: 100 m m in A-C;
20 m m in D-H. All animals are 1-day-old young adults. (A) Wild-type hermaphrodite.
(B) sy622 hermaphrodite. (C) sy665 hermaphrodite. (D) Wild-type male tail. Arrows
indicate wild-type rays. (E) sy622 male tail. (F) sy665 male tail. (G) A sy622 male
harboring a rescuing dpy-22::gfp transgene that produces a full-length DPY-22::GFP
translational fusion protein. (H) A sy622 male harboring a rescuing dpy-22 2548::gfp
transgene, which produces a translational fusion between the first 2548 amino acids of
DPY-22 to GFP.
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otherwise wild-type background, dpy-22 RNAi did not affect
vulval development (data not shown). However, in a sensitized
background consisting of the let-23(sy1) loss-of-function
mutation, dpy-22 RNAi could partially suppress the vulvaless
phenotype of let-23(sy1), similar to the dpy-22 alleles sy622 and
sy665 (Table 3). By contrast, control gfp dsRNA did not
suppress let-23(sy1) (Table 3). Together, these data indicate that
sy622 and sy665 are stronger loss-of-function alleles of dpy-22.
dpy-22 is expressed in vulval precursor cells and is
mislocalized in dpy-22(sy665) animals
DPY-22 is most closely related to human TRAP230 (Ito et al.,
1999; Nagase et al., 1996; Philibert et al., 1998), a component
of human mediator complexes, and KOHTALO (Treisman,
2001), a regulator of cell fate in the Drosophila eye. The fly
and human proteins have similar length, and display 35%
overall identity. DPY-22 is larger than both proteins by ~1000
amino acids, and BLAST analysis indicates that its homology
with TRAP230 and KOHTALO is spread over three regions
(Fig. 2B). These include small regions of identity at the N and
C termini, and a larger region of identity in the middle of the
protein. In all three proteins, the C terminus is rich in
glutamine. Thirty-three percent of the terminal 781 and 589
amino acids are glutamine in DPY-22 and KOHTALO,
respectively, and 41% of the 278 terminal amino acids in
TRAP230 are glutamine. Of the previously isolated nonsense
mutations in dpy-22, bx93 and bx92 are the strongest. bx93
results in the greatest truncation, removing all the amino acids
C-terminal to 2548, including the entire glutamine-rich region.
As dpy-22(sy622) and dpy-22(sy665) cause a number of highly
penetrant phenotypes (Fig. 1; Tables 1, 2) not observed in the
other nonsense mutations, domains N-terminal to the
glutamine-rich region must be important for DPY-22 function.
The nonsense mutation in dpy-22(sy622) would be predicted
to truncate DPY-22 in the largest central region of identity;
however, dpy-22(sy665) is predicted to truncate DPY-22 after
amino acid 2141, close to the end of this region (Fig. 2B). This
observation suggests that another important functional domain
exists between amino acids 2141 and 2548 that does not have
identity with TRAP230 or KOHTALO.
PROSITE analysis of DPY-22 indicated the presence of two
putative nuclear localization signals in this region. To test
whether the stronger phenotypes observed in dpy-22(sy622)
and dpy-22(sy665) animals are correlated with a mislocalized,
non-nuclear form of DPY-22, we constructed transgenes in
which dpy-22 DNA was fused in-frame to the green fluorescent
protein (GFP) open reading frame (Fig. 2C). dpy-22 has been
reported to be expressed in vulval cells, during the later stages
of vulval development (Zhang and Emmons, 2000). We found
that a rescuing (see last section of the Results) fusion of wild-
type DPY-22 to GFP was expressed in the VPCs, the anchor
cell, and hyp7 nuclei at the time of vulval fate specification,
and continued to be expressed in these cells throughout vulval
development (Fig. 3A-F). Wild-type DPY-22 and DPY-22
truncated after amino acid 2548, as generated in dpy-22(bx93)
mutants, directed nuclear expression of GFP (Fig. 3A-H). By
contrast, DPY-22 truncated after amino acid 2141 could not
direct GFP into the nucleus, and instead, caused GFP to
accumulate in the cytoplasm (Fig. 3I,J). These data indicate
that the predicted nuclear localization sequences (NLSs) in this
region are functional, and suggest that the severity of the dpy-
22(sy622) and dpy-22(sy665) phenotypes may result from
mislocalization of the DPY-22 protein, and/or loss of other
functional regions of the protein. 
DPY-22 is a gonad-independent inhibitor of vulval
fate specification of multiple Pn.p cells
let-23(sa62)/+ and let-60(n1046) animals are responsive to
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Table 3. DPY-22 is an inhibitor of vulval development
Relevant genotype % Vul* % Muv† VPC induction‡ n§ P value¶
N2 0 0 3.0±0.0 31
let-23(sa62) 0 98 4.3±0.6 42
let-23(sa62)/+ 0 4 3.1±0.3 26
sy622 0 3 3.0±0.2 35
let-23(sa62)/+; sy622 0 96 4.9±0.8 23 <0.000001 versus let-23(sa62)/+
let-23(sa62)/+; sy622; 0 0 3.0±0.0 24 0.33 versus let-23(sa62)/+
syEx538 [F47A4]
let-23(sa62)/+; sy622; 0 14 3.1±0.2 22 0.88 versus let-23(sa62)/+
syEx539 [dpy-22 PCR]
dpy-22(bx93) 0 0 3.0±0.0 23
let-23(sa62)/+; dpy-22(bx93) 0 40 3.3±0.3 20 0.032 versus let-23(sa62)/+
let-23(sa62)/+; dpy-22(sy622)/+ 0 15 3.1±0.3 26 0.42 versus let-23(sa62)/+
let-23(sa62)/+; dpy-22(sy622)/dpy-22(bx93) 0 71 3.7±0.6 24 0.00004 versus let-23(sa62)/+
let-23(sy1) 100 0 0.5±0.9 24
let-23(sy1); gfp RNAi 100 0 0.2±0.4 41
let-23(sy1); dpy-22 RNAi 79 6 1.9±0.9 34 <0.000001 versus gfp RNAi
let-23(sa62)/+; dpy-22(sy622); 0 13 3.1±0.3 23 0.55 versus let-23(sa62)/+
syEx554 [dpy-22:: gfp]
let-23(sa62)/+; dpy-22(sy622); 0 15 3.1±0.3 20 0.60 versus let-23(sa62)/+
syEx558 [dpy-22 2548:: gfp]
*Vulvaless. Percentage of animals that have less than three VPCs adopting vulval fates.
†Multivulva. Percentage of animals that have more than three VPCs adopting vulval fates.
‡Average number of VPCs that adopt vulval fates.
§Number of animals assayed.
¶P values were calculated for VPC induction using Student’s t-test.
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LIN-3 (Chang et al., 2000; Katz et al., 1996; Sundaram and
Han, 1995) (Table 3), and suppression of the lin-3(n378) and
let-23(sy1) hypomorphic mutations could in principle occur
through elevated production of LIN-3. As DPY-22::GFP is
expressed in the anchor cell and the VPCs (Fig. 3), we tested
whether dpy-22 affects vulval fate specification by modulating
the production of LIN-3 from the gonad. We ablated the
gonadal primordium in let-23(sa62)/+ and let-23(sa62)/+;
dpy-22(sy622) early L1 larvae. Gonad-ablated let-23(sa62)/+
animals displayed very little vulval fate specification in any of
the Pn.p cells (Table 4). By contrast, dpy-22(sy622)
increased the frequency of vulval fate specification in
all six VPCs in this background (Table 4), indicating
that DPY-22 does not act primarily by regulating LIN-
3 production from the gonad, and that the fates of all
the VPCs are regulated by DPY-22. 
DPY-22-mediated inhibition of vulval-fate
specification involves transcription factors
other than BAR-1 ( b -catenin)
In males, a bar-1(b -catenin) null allele, ga80, does not
affect ray development on its own (Zhang and Emmons,
2000). However, it reduces the degree to which dpy-
22(bx92) can restore wild-type ray development in a
pal-1(e2091) mutant background (Zhang and Emmons,
2000). This property has led to the proposal that in the
presence of the pal-1(e2091) regulatory region
mutation, DPY-22 inhibits BAR-1-dependent regulation
of the pal-1 gene (Zhang and Emmons, 2000). WNT/ b -
catenin signaling also promotes vulval fate
specification, parallel to the LET-23-LET-60 pathway.
A null mutation in bar-1 results in an incompletely
penetrant vulvaless phenotype (Table 5) (Eisenmann et
al., 1998), and a loss-of-function mutation in the axin-
like inhibitor of WNT signaling, pry-1 (Korswagen et
al., 2002; Maloof et al., 1999), causes ectopic vulval
fate specification (Table 5) (Gleason et al., 2002).
Furthermore, hyperactivated WNT signaling can bypass
loss-of-function mutations in the let-23 pathway
(Gleason et al., 2002). We therefore tested whether
relief of inhibition of BAR-1 might account for the
interactions between our dpy-22 alleles and mutations
in the LET-23 pathway during vulval development.
We linked two bar-1 mutations to dpy-22(sy622). bar-
1(mu63) encodes a weak loss-of-function mutation
(Maloof et al., 1999) that does not confer defects in
vulval development on its own (Table 5). The mis-sense
mutation in this allele results in a protein with a G524D
change (see Materials and Methods). We hypothesized
that under conditions where a phenotype was dependent
on elevated BAR-1 activity, bar-1(mu63) should
quantitatively reduce it. Consistent with this notion, bar-
1(mu63) suppresses the ectopic mab-5 expression and
poly ray phenotypes observed in pry-1(mu38) animals
(Maloof et al., 1999). As a control, we tested whether
bar-1(mu63) also could reduce vulval induction in a
background where WNT signaling was specifically
hyperactivated. We built a pry-1(mu38); let-23(sy1)
double mutant and, as recently reported (Gleason et al.,
2002), found that excess WNT signaling could strongly
suppress this let-23 reduction-of-function allele (Table
5). bar-1(mu63) reduced the ability of pry-1(mu38) to suppress
let-23(sy1) (Table 5), indicating that bar-1(mu63) can be used to
define conditions under which WNT signaling is hyperactivated
during vulval development. Although dpy-22(sy622) is a weaker
suppressor of let-23(sy1) than is pry-1(mu38), its ability to
suppress the let-23 mutation was not reduced in the presence of
the bar-1(mu63) mutation (Table 5). These data suggest that
DPY-22 does not interfere with vulval development through
inhibition of BAR-1. We also examined the body size, egg-
laying behavior and male rays in bar-1(mu63) dpy-22(sy622)
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Fig. 2. Structure of injected transgenes, and DPY-22 and TRAP230 proteins.
(A) Graphical depiction of the PCR fragment amplified from cosmid F47A4
used for rescue experiments. PCR was used to amplify the region between
21115 and 6044 of F47A4. This region contains the entire predicted dpy-22
open reading frame (18942-7241) and parts of the last two exons from
F47A4.3. (B) Structural organization of DPY-22 and TRAP230 proteins.
Numbers above the proteins refer to amino acid positions. Hatched area
represents a glutamine-rich region. Gray areas represent regions of amino acid
identity between DPY-22 and TRAP230, as defined by BLAST, with the
percentage identity listed below. The positions of the dpy-22 nonsense
mutations used in this study are indicated. (C) Structure of DPY-22::GFP
fusion proteins encoded by transgenic constructs. DPY-22::GFP is a fusion of
the full-length wild-type DPY-22 to non nuclear-localized GFP. DPY-22
2548::GFP and DPY-22 2141::GFP are fusions between the first 2548 and
2141 amino acids of DPY-22, respectively, to non nuclear-localized GFP.
Black boxes indicate putative nuclear localization sequences predicted by
PROSITE. Hatched area represents a glutamine-rich region. Gray areas
indicate GFP amino acids. 
64
animals, and found none of dpy-22(sy622) phenotypes to be
suppressed by the bar-1 mutation (Table 2).
As our data suggested that DPY-22 might primarily inhibit the
output of the RAS pathway, rather than the WNT pathway,
during vulval development, we tested whether the dpy-22
(sy622) mutation was strong enough to compensate for the
absence of BAR-1 in bar-1(ga80) null mutants. bar-1(ga80)
dpy-22(sy622) double mutants were sick, but still displayed the
bar-1(ga80) vulvaless phenotype (Table 5). Because the gain-of-
function let-60(n1046) allele, which is far stronger than dpy-
22(sy622) [(Table 1) 73% Muv and 4.0 cell induction versus 3%
Muv and 3.0 cell induction, respectively] only suppresses bar-
1(ga80) to wild-type levels, we hypothesized that failure of dpy-
22(sy622) to suppress bar-1(ga80) might result from insufficient
activation of the RAS pathway. Therefore, we used a more
sensitive assay to test further whether DPY-22 acts
independently of BAR-1 during vulval development. let-
60(n1046gf); bar-1(ga80) double mutants are mostly wild type
and are mutually suppressed with regards to the let-60(n1046)
multivulva phenotype and the bar-1(ga80) vulvaless phenotype
(Table 5). As dpy-22(sy622) is a strong enhancer of the gain-of-
function let-60(n1046) allele (Table 1), we asked whether dpy-
22(sy622) could still enhance activated RAS even in the absence
of BAR-1 protein. let-60(n1046); bar-1(ga80) dpy-22(sy622)
triple mutants were very sick, but survived to L4 and displayed
much more vulval induction than did let-60(n1046); bar-1(ga80)
double mutants (Table 5). The enhanced vulval induction in the
triple mutants was abrogated by the presence of the dpy-22-
rescuing cosmid, F47A4, demonstrating that enhancement in the
triple mutant was indeed due to loss of DPY-22 activity (Table
5). These data indicate that DPY-22 can regulate vulval induction
independently of any effects on BAR-1 activity. 
The C-terminal glutamine-rich region is dispensable
for most of the activity of DPY-22
The absence of body size, egg-laying, and ray defects, and the
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Fig. 3. DPY-22::GFP is expressed in
the nuclei of vulval cells, and is
mislocalized by the dpy-22(sy665)
mutation. Left-hand images are
Nomarski, and right-hand images
are fluorescence. Scale bars: 20 m m.
Arrows indicate some of the vulval
cells and arrowheads indicate the
anchor cells. (A-F) dpy-22(sy622)
hermaphrodites rescued with a dpy-
22::gfp transgene that encodes a
fusion of full-length wild-type DPY-
22 to GFP. (A,B) Two-cell stage at
the onset of vulval fate
specification. (C,D) Four-cell stage
of vulval development. (E,F) Eight-
cell stage of vulval development.
(G,H) dpy-22(sy622)
hermaphrodites rescued with a dpy-
22 2548::gfp transgene, which
encodes a fusion of the first 2548
amino acids of DPY-22 to GFP.
(I,J) pha-1(e2123ts)-rescued
animals carrying a dpy-22 2141::gfp
transgene, which encodes a fusion
of the first 2141 amino acids of
DPY-22 to GFP. Wild-type DPY-22
and DPY-22 truncated after amino
acid 2548 direct GFP to the nucleus,
but not DPY-22 truncated after
amino acid 2141.
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presence of only a weak vulval phenotype in dpy-22(bx93)
mutants, suggest that the glutamine-rich region is dispensable
for the function of DPY-22 in these processes. Because it is
possible that small amounts of wild-type DPY-22 might be
produced through translational readthrough in dpy-22(bx93)
mutants, we directly examined the functional properties of a
DPY-22 protein that completely lacks the glutamine-rich
region. We injected a construct consisting of dpy-22 DNA
ending with the codon for amino acid 2548, fused in-frame to
the GFP open reading frame, into dpy-22(sy622) animals (Fig.
2C). This transgene should produce a protein similar to that
made in dpy-22(bx93) animals, which ends after amino acid
2548, before the beginning of the glutamine-rich region. Wild-
type and glutamine-deleted DPY-22 fully rescued the body
length, egg-laying and male tail defects observed in dpy-
22(sy622) mutants (Fig. 1G,H; Table 2). Furthermore,
glutamine-deleted DPY-22 also rescued the ectopic vulval
fate specification observed in a let-23(sa62)/+; dpy-22(sy622)
background, comparable with wild-type DPY-22 (Table 3).
These results demonstrate that the glutamine-rich region is not
essential for the majority of functions performed by DPY-22.
DISCUSSION
We have used a genetic approach to study mechanisms by
which a diffusible growth factor can invariantly trigger a
response in a particular cell within a field of competent cells.
Initially using vulval tissue formation by male Pn.p cells as an
assay, we identified two mutations in dpy-22 that generally
promote the activity of LET-23 in Pn.p cells, regardless of the
sex of the animal. Our genetic analysis using the dpy-
22(sy622), dpy-22(sy665) and dpy-22(bx93) alleles, as well as
RNAi against dpy-22, indicate that DPY-22 is normally an
inhibitor of vulval fate specification (Tables 1, 3). As DPY-22
can act as an inhibitor in the absence of the LIN-3-producing
anchor cell (Table 4), and DPY-22 is expressed in the vulval
precursor cells during the time of vulval fate specification (Fig.
Table 4. DPY-22 is a gonad-independent inhibitor of vulval fates of multiple VPCs
Frequency of VPC adopting vulval cell fate§
Relevant genotype Gonad* % Vul† % Muv‡ P3.p P4.p P5.p P6.p P7.p P8.p n¶
N2 + 0 0 0 0 100 100 100 0 31
N2 – 100 0 0 0 0 0 0 0 14
let-23(sa62) + 0 95 43 95 100 100 100 0 42
let-23(sa62) – 0 94 71 94 100 94 82 41 17
let-23(sa62)/+ + 0 2 15 15 100 100 100 0 66
let-23(sa62)/+ – 100 0 0 0 4 17 0 0 24
let-23(sa62)/+; dpy-22(sy622) + 0 96 78 91 96 100 100 57 23
let-23(sa62)/+; dpy-22(sy622) – 0 50 60 87 100 60 33 33 15
*Absence or presence of gonad. The gonadal primoridum was removed by laser ablation during the L1 larval stage.
†Vulvaless. Percentage of animals that have less than three VPCs adopting vulval fates.
‡Multivulva. Percentage of animals that have more than three VPCs adopting vulval fates.
§Percentage of times that a particular VPC gives rise to some vulval cells.
¶n, number of animals assayed.
Table 5. Inhibition by DPY-22 involves transcription factors other than BAR-1
Relevant genotype % Vul* % Muv† VPC induction‡ n§ P value¶
dpy-22(sy622) 0 3 3.0±0.2 35
bar-1(ga80) 55 0 2.3±0.8 20
bar-1(mu63) 0 0 3.0±0.0 20
pry-1(mu38) 26 22 2.9±0.5 23
let-60(n1046) 0 73 4.0±0.8 22
bar-1(mu63) dpy-22(sy622) 0 15 3.2±0.4 20
bar-1(ga80) dpy-22(sy622) 55 0 2.3±0.9 22
let-23(sy1) 100 0 0.5±0.9 24
let-23(sy1); bar-1(mu63) 100 0 0.1±0.4 22
pry-1(mu38); let-23(sy1) 8 84 4.0±0.9 25 <0.000001 versus let-23(sy1)
pry-1(mu38); let-23(sy1); bar-1(mu63) 52 30 2.7±0.9 27 0.00002 versus pry-1(mu38); let-23(sy1)
let-23(sy1); dpy-22(sy622) 75 0 2.1±0.9 20 <0.000001 versus let-23(sy1)
let-23(sy1); bar-1(mu63) dpy-22(sy622) 50 10 2.5±0.8 20 0.09 versus let-23(sy1); dpy-22(sy622)
let-60(n1046); bar-1(ga80) 0 3 3.0±0.1 29
let-60(n1046); bar-1(ga80) dpy-22(sy622) 0 100 5.0±0.7 22 <0.000001 versus let-60(n1046); bar-1(ga80)
let-60(n1046); bar-1(ga80) dpy-22(sy622); 0 15 3.1±0.3 54 0.05 versus let-60(n1046); bar-1(ga80)
syEx538 [F47A4] <0.000001 versus let-60(n1046); bar-1(ga80) dpy-22(sy622)
*Vulvaless. Percentage of animals that have less than three VPCs adopting vulval fates.
†Multivulva. Percentage of animals that have more than three VPCs adopting vulval fates.
‡Average number of VPCs that adopt vulval fates.
§Number of animals assayed.
¶P values were calculated for VPC induction using Student’s t-test.
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3B), we favor the idea that part of its function is executed in
the VPCs. The ability of our dpy-22 mutations to promote
vulval fate specification in P5.p-P7.p, under conditions where
RAS signaling is reduced (Tables 1, 4), indicates that DPY-22
acts as an inhibitor in all the VPCs, not just the VPCs that never
adopt vulval fates (P3.p, P4.p and P8.p). The dpy-22(sy622)
and dpy-22(sy665) mutations do not bypass the RAS pathway
as they cannot fully suppress lin-3 and let-23 reduction-of-
function mutations (Table 1). This suggests that DPY-22 acts
directly on the RAS pathway or a pathway that cooperates with
the RAS pathway and converges on a common target(s). 
Besides the RAS pathway, LIN-12/NOTCH and WNT
promote vulval fates. However, LIN-12 and RAS antagonize
each other with respect to the type of vulval fate that is induced
(Berset et al., 2001; Wang and Sternberg, 1999). High levels
of LIN-12 signaling promote secondary vulval fates (Sternberg
and Horvitz, 1989), and high levels of RAS signaling promote
primary vulval fates (Katz et al., 1995). In our double mutants
consisting of dpy-22 and let-23 pathway mutations, P6.p
induction is restored (Table 1), and all animals displaying full
vulval induction have correctly patterned vulvae consisting of
2°-1°-2° fates for P5.p-P7.p. These data indicate that dpy-22
mutations cooperate with RAS to induce the primary fate in
P6.p, rather than antagonize it, and suggest that DPY-22 does
not act primarily by inhibiting the LIN-12 pathway.
DPY-22 has previously been described as an inhibitor of
BAR-1-dependent WNT signaling (Zhang and Emmons,
2000). In contrast to the LIN-12-RAS relationship, RAS and
WNT signaling are known to converge on at least one common
target, necessary for vulval development, lin-39 (Eisenmann et
al., 1998; Maloof and Kenyon, 1998). Thus, DPY-22 inhibition
likely occurs through interference with RAS and/or WNT
signaling. However, our triple mutant analysis with a bar-1 null
mutation indicates that DPY-22 can inhibit activated RAS even
in the absence of BAR-1 protein (Table 5). Together with our
molecular data that the glutamine-rich region, which is
necessary for inhibition of BAR-1-dependent ray development
(Zhang and Emmons, 2000), is dispensable for inhibition of
vulval development (Table 3), we propose that DPY-22 largely
acts on the RAS pathway, rather than the WNT pathway, to
inhibit vulval development. The strong gain-of-function let-
60(n1046) allele only suppresses the bar-1(ga80) null mutation
to wild type, and is itself suppressed for its multivulva
phenotype by the bar-1(ga80) mutation (Table 5).
Furthermore, our dpy-22(sy622) mutation which does not
cause a strong multivulva phenotype, partially suppresses the
moderate vulvaless phenotype of let-23 pathway mutations
(Table 1), but not the weak vulvaless phenotype of bar-1(ga80)
(Table 5). These results suggest that shared targets between
RAS and WNT signaling are unequally activated by the two
pathways. In addition, it is likely that the WNT pathway has
targets that are not shared with the RAS pathway.
Most inhibitors of vulval development affect all six VPCs.
This observation is consistent with a model in which negative
regulators of the RAS pathway raise the requirement for the
amount of pathway activation needed to generate a biological
response. Although the LIN-3 growth factor might diffuse
outside of the source anchor cell, only P6.p, because of its
proximity to the anchor cell, achieves sufficient pathway
activation to adopt a primary vulval fate. A surprising number
of points in the pathway must be negatively regulated,
presumably to achieve invariant positional specificity for the
response to LIN-3. SLI-1(c-CBL) (Jongeward et al., 1995;
Yoon et al., 1995), GAP-1 (Hajnal et al., 1997) and LIP-1
(MAPK phosphatase) (Berset et al., 2001) appear to directly
regulate LET-23 (EGFR), LET-60 (RAS) and SUR-1/MPK-
1(MAP kinase), respectively, while ARK-1 might control some
aspect of SEM-5(GRB2)-dependent RAS activation (Hopper et
al., 2000). 
Ultimately, the end point for growth factor signaling can be
considered to be a change in RNA Pol II activity on specific
promoters. Thus, in principle, sequence-specific and global
regulators of transcription also might play important roles in
regulating the output of the RAS pathway. Genetic studies
have identified LIN-1, an Ets-domain sequence-specific DNA-
binding protein as an inhibitor of vulval fate specification
(Beitel et al., 1995). Global regulators of transcription broadly
include chromatin remodeling proteins, RNA Pol II and the
general transcription factors, and components of the mediator
complex, which promote the activity of sequence-specific
activators and repressors. Mutations in the synmuv genes lin-
35(RB) and lin-53(RBAP48) have suggested that a histone
deacetylase complex is inhibitory towards vulval fate
specification (Lu and Horvitz, 1998). In support of this,
experiments that directly examine HDAC-1 and components of
the NURD complex have provided some evidence for their
inhibitory roles (Chen and Han, 2001; Lu and Horvitz, 1998;
Solari and Ahringer, 2000). Our work with dpy-22, which is
most related to humanTRAP230 (Ito et al., 1999; Nagase et al.,
1996; Philibert et al., 1998), now indicates that a specific
component of the mediator also can act as an inhibitor of a
RAS-dependent response.
At least 20 components of the mediator complex have been
identified in yeast. Ten are essential for viability and seven of
these appear to have related counterparts in higher species
including C. elegans (for reviews, see Boube et al., 2002;
Gustafsson and Samuelsson, 2001; Myers and Kornberg, 2000;
Woychik and Hampsey, 2002). By contrast, the remaining
yeast mediator components do not have clear orthologs in
higher species. This has led to the proposal that these
components and their counterparts in other species might not
peform core mediator functions but, instead, specifically
integrate information from rapidly evolving transcription factor
families. Consistent with this model, mutation or RNA
interference against the conserved components in C. elegans
result in early lethality, or multiple phenotypes in the rare
animals escaping lethality (Kwon et al., 1999; Kwon et al.,
2001; Kwon and Lee, 2001). By contrast, the metazoan-
specific mediator, sur-2 (Boyer et al., 1999; Singh and Han,
1995), is not essential for viability, and single mutants have a
strong vulvaless phenotype, resembling a RAS pathway
mutation (Singh and Han, 1995). Similarly, prior to the
discovery that sop-1 was allelic to dpy-22, it was thought that
mutations in C. elegans TRAP230, another metazoan-specific
mediator component, do not affect viability and cause one
major phenotype, which is the relief of inhibition on BAR-1-
dependent regulation of pal-1 expression in males (Zhang and
Emmons, 2000).
However, our alleles of dpy-22, which cause more severe
truncations of the protein and mislocalize it (Fig. 3I), result in
multiple developmental and behavioral phenotypes (Fig. 1,
Table 2) that do not appear to be restricted to one specific
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signaling pathway. Some of these include an overall reduction
in body length by 30%, a Dpy appearance, partial sterility (data
not shown), abnormal ray development in the male tail and an
egg-laying defect that does not result from the absence of
vulval tissue or sex muscles, or a functional uterine-vulval
connection (data not shown). We have also found that DPY-22
antagonizes vulval fates specified by activated RAS, and that
the major target(s) of this inhibition is distinct from BAR-1
(Table 5). These findings are consistent with the original
description of dpy-22(e652) phenotypes, and the observation
that dpy-22(e652) enhances the multivulva phenotypes of lin-
53(n833); lin-15(n767) and lin-15(n765) males (Meneely and
Wood, 1987). Because we observe effects of dpy-22 mutations
on vulval development with multiple non-X-linked alleles in
the RAS pathway, we do not think that DPY-22 acts on vulval
development through regulation of dosage compensation from
the X-chromosome, as originally proposed (Meneely and
Wood, 1987). Neither loss-of-function nor gain-of-function
mutants in the RAS pathway result in the body size or ray
defects observed in our mutants, and bar-1(mu63) and bar-
1(ga80) do not suppress at least the body size phenotype of
our dpy-22 mutants (Table 2, data not shown). These results
suggest that transcription factors downstream of other
signaling pathway also must be regulated by DPY-22.
Similarly, recent data with dpy-22(bx92) and sur-2 double
mutants have shown a synthetic loss of rays (Zhang and
Emmons, 2002), indicating SUR-2 also can function in
pathways distinct from those using RAS and BAR-1. Thus, it
is likely that DPY-22 and SUR-2 relay information from
multiple activator/promoter contexts to RNA Pol II, but how
they do it, and their relative contribution at a given promoter
may be different.
The molecular identification of our new dpy-22 alleles
provides some insight into how a mediator component such as
DPY-22 can have general and specific functions, depending on
the promoter context. Although dpy-22(bx93), which deletes
the entire glutamine-rich domain of DPY-22, has a weak ability
to promote ectopic vulval fate specification in the presence of
activated LET-23, it has a profound ability to alleviate
inhibition on BAR-1-dependent regulation of the pal-1 gene
(Zhang and Emmons, 2000). Furthermore, whereas a transgene
harboring nonsense mutations affecting the glutamine-rich
domain cannot restore inhibition to the pal-1 gene as well as a
wild-type dpy-22 transgene (Zhang and Emmons, 2000), we
find that a transgene completely lacking the glutamine-rich
domain has the same activity as a wild-type transgene in
rescuing vulval fate specification (Table 3), ray development
(Fig. 1), body size and egg-laying defects (Table 2). The
glutamine-rich region thus defines a domain that probably
distinguishes promoter/activator-dependent activity for DPY-
22. Inhibition of BAR-1-dependent pal-1 expression is
critically dependent on this domain, but not the activity of
DPY-22 in the other pathways studied in this work. BLAST
analysis (Boube et al., 2002; Gustafsson and Samuelsson,
2001) indicates the N-terminal region of TRAP230 is similar
to both DPY-22 and SRB8 (Hengartner et al., 1995), a yeast
mediator component without a clear ortholog in metazoans.
SRB8 is responsible for recruiting (Myer and Young, 1998) the
SRB10/SRB11 cyclin/cdk complex (Liao et al., 1995) that
represses Pol II-dependent transcription on many promoters
(Holstege et al., 1998). In cases where DPY-22/TRAP230
represses transcription, this function might be dependent on the
SRB8-like domain, but modulated by the metazoan-specific
domains. TRAP230 and PCQAP (Berti et al., 2001), two
glutamine-rich components of human mediator complexes
have been implicated in human disease. TRAP230 has been
reported to undergo a 12 bp expansion in a region encoding the
glutamine-rich domain in a subset of mentally retarded
individuals (Philibert et al., 1998), and PCQAP is in the 22q11
deletion associated with DiGeorge syndrome (Berti et al.,
2001). If TRAP230 and PCQAP contribute to these conditions,
one would expect them to arise out of loss of specific and
general functions, respectively.
Although compared with sequence-specific DNA-binding
proteins, proteins involved in nucleosome displacement,
histone acetylation and deacetylation, and components of
the mediator complex appear to be global regulators of
transcription, these global regulators may not act equally at all
promoters. In particular, multiple chromatin remodeling and
histone acetylation and deacetylation complexes with distinct
subunit composition, substrate specificity and activator
preferences have been described (reviewed by Emerson, 2002;
Narlikar et al., 2002). Although it is still controversial whether
distinct mediator complexes are associated with the RNA Pol
II holoenzyme at a given promoter, mutations in different
components have different effects on gene expression in yeast
(Holstege et al., 1998; Myers et al., 1999). Some mediator
components may perform unique functions for distinct
activators or repressors, while others may be used to varying
degrees or redundantly with other components. Finally, as in
the case of DPY-22, a single component may use distinct
domains to regulate transcription on different promoters.
Genetic studies thus demonstrate that a specific component of
the mediator provides an important point for regulating the
output of the RAS pathway, and that specific mutations can be
generated with distinct properties, which might contribute to
disease in humans. 
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